Skip main navigation
Close Drawer MenuOpen Drawer Menu
APA Publishing Logo

The American Psychiatric Association (APA) has updated its Privacy Policy and Terms of Use, including with new information specifically addressed to individuals in the European Economic Area. As described in the Privacy Policy and Terms of Use, this website utilizes cookies, including for the purpose of offering an optimal online experience and services tailored to your preferences.

Please read the entire Privacy Policy and Terms of Use. By closing this message, browsing this website, continuing the navigation, or otherwise continuing to use the APA's websites, you confirm that you understand and accept the terms of the Privacy Policy and Terms of Use, including the utilization of cookies.

×
Back to table of contents
Information on Host City and Meeting HighlightsFull Access

Sessions on HIV/AIDS Address Medical, Neuropsychiatric Issues

Published Online:21 Feb 2003https://doi.org/10.1176/pn.38.4.0049

APA’s Office of HIV Psychiatry and Committee on AIDS will offer several HIV/AIDS-related programs both for psychiatry residents and psychiatrists with various backgrounds and experiences. Each program will provide current information on HIV/AIDS and the central nervous system. This year presenters will aim to provide concrete and practical suggestions for the care of HIV-infected patients. All the programs will provide a forum for psychiatrists to discuss individual clinical cases.

Sunday, May 18, noon to 4:30 p.m.

• Residents Program: The Committee on AIDS will again present a program designed for psychiatry residents. The program will provide up-to-date information on the most important things that psychiatrists need to know about HIV psychiatry. The program will include segments on differential diagnosis and psychopharmacology, as well as case discussions.

Tuesday, May 20, 9 a.m. to 10:30 a.m.

• Psychiatric Management of HIV, Hepatitis C, and Substance Abuse: This Committee on AIDS component workshop will offer guidelines for the differential diagnosis of HIV infection. Presenters will focus on co-occurring HIV/AIDS and hepatitis C, as well as co-occurring HIV/AIDS and substance abuse. Each presentation will provide psychiatrists with tools for evaluating and treating patients, along with strategies to provide optimum patient care.

Wednesday, May 21, 2 p.m. to 5 p.m.

• Neuropsychiatric Aspects of HIV/AIDS: An Overview (Part 1): This session is the first of two symposia designed to provide a full clinical update for psychiatrists. Part 1 will provide an HIV treatment update and information on CNS complications. An expert clinical panel will present case examples and provide sample treatment options and management strategies. Participants have the option to follow all three segments of the symposium in their entirety or sit in on one segment only.

Thursday, May 22, 2 p.m. to 5 p.m.

• Neuropsychiatric Aspects of HIV/AIDS: Evaluation and Treatment (Part 2): This session is intended to provide psychiatrists with practical suggestions for the clinical care of the HIV/AIDS patient. The symposium will begin with the presentation “Evaluating the Neuropsychiatric Patient,” followed by “Six Things You Need to Know: Drug-Drug Interactions.” The symposium will conclude with a presentation on managing depression and anxiety. Participants are invited to ask questions following each lecture.

Saturday to Wednesday, May 17 to 21

• Resource Center: Visit the Office on HIV Psychiatry booth at the APA Resource Center in the Exhibit Hall to learn more about the programs and resources available to help in training efforts or clinical practice. The exhibit will offer national and local clinical and patient information including books, newsletters, training curricula, brochures, articles, and lists of Web resources. ▪